Results
- Showing results for:
- Reset all filters
Search results
-
Journal articleIaniro G, Mullish BH, Kelly CR, et al., 2020,
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
, Gut, Vol: 69, Pages: 1555-1563, ISSN: 0017-5749<jats:p> The COVID-19 pandemic has led to an exponential increase in SARS-CoV-2 infections and associated deaths, and represents a significant challenge to healthcare professionals and facilities. Individual countries have taken several prevention and containment actions to control the spread of infection, including measures to guarantee safety of both healthcare professionals and patients who are at increased risk of infection from COVID-19. Faecal microbiota transplantation (FMT) has a well-established role in the treatment of <jats:italic>Clostridioides difficile</jats:italic> infection. In the time of the pandemic, FMT centres and stool banks are required to adopt a workflow that continues to ensure reliable patient access to FMT while maintaining safety and quality of procedures. In this position paper, based on the best available evidence, worldwide FMT experts provide guidance on issues relating to the impact of COVID-19 on FMT, including patient selection, donor recruitment and selection, stool manufacturing, FMT procedures, patient follow-up and research activities. </jats:p>
-
Journal articleSegal JP, Mullish BH, Quraishi MN, et al., 2020,
Letter: faecal microbiota transplantation for IBS
, Alimentary Pharmacology & Therapeutics, Vol: 52, Pages: 556-557, ISSN: 0269-2813<jats:p><jats:bold>LINKED CONTENT</jats:bold></jats:p><jats:p>This article is linked to Lahtinen et al papers. To view these articles, visit<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/apt.15810">https://doi.org/10.1111/apt.15810</jats:ext-link> and <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/apt.15875">https://doi.org/10.1111/apt.15875</jats:ext-link>.</jats:p>
-
Journal articleMcIlroy JR, Mullish BH, Goldenberg SD, et al., 2020,
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?
, Clinical Immunology, ISSN: 1521-6616 -
Journal articleVieira-Silva S, Falony G, Belda E, et al., 2020,
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
, NATURE, Vol: 581, Pages: 310-+, ISSN: 0028-0836- Cite
- Citations: 201
-
Journal articleAllegretti JR, Hurtado J, Carrellas M, et al., 2020,
121 ULCERATIVE COLITIS PATIENTS ACHEIVE MORE ROBUST ENGRAFTMENT COMPARED TO PATIENTS WITH CROHN'S DISEASE AFTER FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF RECURRENT C. DIFFICLE INFECTION
, Gastroenterology, Vol: 158, Pages: S-22, ISSN: 0016-5085 -
Journal articleBlanco JM, Liu Z, Selvarajah U, et al., 2020,
Sa1923 identification of new associations between psoriatic arthritis and the gut microbiota, a phenomic study
, Gastroenterology, Vol: 158, Pages: S-481, ISSN: 0016-5085 -
Journal articleMonaghan T, Russell L, Rosati E, et al., 2020,
Mo1939 TEMPORAL MODULATION OF TCR REPERTOIRE FOLLOWING SEQUENTIAL FMT TREATMENT IN PATIENTS WITH SEVERE OR FULMINANT CLOSTRIDIOIDES DIFFICILE INFECTION
, Gastroenterology, Vol: 158, ISSN: 0016-5085 -
Journal articleAllegretti JR, Kassam Z, Hurtado J, et al., 2020,
Tu1909 IMPACT OF FECAL MICROBIOTA TRANSPLANTATION ON PREVENTION OF METABOLIC SYNDROME AMONG PATIENTS WITH OBESITY
, Gastroenterology, Vol: 158, ISSN: 0016-5085 -
Conference paperGhani R, Mullish BH, McDonald JA, et al., 2020,
1144 FECAL MICROBIOTA TRANSPLANT FOR MULTI-DRUG RESISTANT ORGANISMS: IMPROVED CLINICAL OUTCOMES BEYOND INTESTINAL DECOLONISATION
, Publisher: Elsevier BV, ISSN: 0016-5085 -
Conference paperMartinez-Gili L, McDonald JA, Liu Z, et al., 2020,
644 identification of novel changes in microbially-derived metabolites after fecal microbiota transplant for recurrent clostridioides difficile infection
, Publisher: Elsevier BV, Pages: S-138-S-139, ISSN: 0016-5085
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.
General enquiries
For any enquiries about the Microbiome Network at Imperial, please contact: